---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-019783"
form_type: "8-K"
ticker: "JUNS"
cik: "0001679628"
company_name: "JUPITER NEUROSCIENCES, INC."
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:11:39.791387+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Jupiter Neurosciences secures up to $20M flexible financing from Yorkville; $4M funded at signing

## Summary
- Initial $4M pre-paid advance funded via convertible note with $1.50 fixed conversion price and 7% OID.
- Additional $2M pre-paid advance contingent on registration statement and stockholder approval; total $6M pre-paid.
- Up to $14M available under SEPA over 24 months subject to conditions; proceeds to fund Phase 2 Parkinson's trial and Nugevia growth.
- Yorkville receives 131,909 commitment shares and $25K structuring fee; issuance subject to 19.99% Exchange Cap unless stockholder approval obtained.
- Convertible notes bear 8% interest, mature Oct 24, 2026; repayment via cash or advance notices under SEPA.

## SEC filing metadata
- accession: 0001493152-25-019783
- form_type: 8-K
- ticker: JUNS
- cik: 0001679628
- company_name: JUPITER NEUROSCIENCES, INC.
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/0001493152-25-019783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-019783
- JSON: https://secwatch.observer/filing/0001493152-25-019783.json
- Plain text: https://secwatch.observer/filing/0001493152-25-019783.txt

## Key facts
- Debt Financings
  JUPITER NEUROSCIENCES, INC. incurred convertible notes of $4.0 million with YA II PN, LTD.
  - Instrument: convertible notes
  - Principal: $4.0 million
  - Counterparty: YA II PN, LTD
  - Event: incurrence
  source text: The first Pre-Paid Advance in the amount of $3,720,000 was disbursed to the Company on October 27, 2025, in exchange for the Company’s issuance to Yorkville of a Convertible Note in the principal amount of $4.0 million, which was issued with an “original issue discount” (“OID”) of 7.0% (or $280,000) and is initially convertible into Common Stock at a fixed conversion price of $1.50 per share (subject to adjustment as provided in such Convertible Note) (the “First Convertible Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1679628/000149315225019783/0001493152-25-019783-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.